Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Error message

Could not retrieve the oEmbed resource.

Biology Behind Targeted Therapy for Lymphomas

Dr. Staudt talks about how ibrutinib is a very specific agent that has a high degree of efficacy with only modest side effects in treating the ABC form of Diffuse B-cell Lymphoma

  • Posted: